Several mechanisms of tamoxifen resistance have been investigated, including the overexpression of Cyclin D1, a cell cycle regulator that promotes cell proliferation, which is overexpressed in a subset of breast cancers [9]. The gene discussed is CCND1; the disease is breast cancer.